In October 2002, 22 scientists, nine WHO Secretariat members, and two drug industry representatives to draw up draft guidelines on the use of antivirals and vaccines for influenza. These form the basis of advice issued to the world two years later. Included in this was three annexes—each drawn up by an eminent scientist present at the original meeting. The WHO would be expected to examine any financial link these three scientists and any others advising it would have with pharmaceutical companies. It said it did but it’s refusing to make public the details. In 2004, this guidance was distributed to nations as the definitive thinking on on pandemic planning. It was a stamp of approval that helped spark a worldwide rush for the drugs. Around $10 billion has since been spent on Roche’s Tamiflu and another $2 billion on rival Relenza made by GSK.
Did Big Pharma and WHO Corruption Trick the World Into Tamiflu?
Published February 7, 2018 | Best in Video